<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks2.jpg" NAME"4 Biotech Stocks Worthy Enough to be Brokers' Favorites" ALT"4 Biotech Stocks Worthy Enough to be Brokers' Favorites"February 7, 2017By Mark Terry, BioSpace.com Breaking News StaffWhen in Rome...…
Life Sciences Jobs ... Source: BioSpace
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-job-cuts.jpg" NAME"GE Healthcare to Shutter Maryland Plant, Nearly 200 Employees Affected" ALT"Merck KGaA Spinout Prexton Nabs $31 Million to Fund Phase II Parkinson's TrialsGE Healthcare to Shutter Maryland Plant,…
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-Merck-KGaA-Germany.jpg" NAME"Merck KGaA Spinout Prexton Nabs $31 Million to Fund Phase II Parkinson's Trials" ALT"Merck KGaA Spinout Prexton Nabs $31 Million to Fund Phase II Parkinson's Trials"February 7, 2017By…
Life Sciences Jobs ... Source: BioSpace
Teva Pharmaceuticals has been named in a patent infringement lawsuit as it attempts to develop a generic version of Belbuca, a long-acting opioid painkiller sponsored by BioDelivery Sciences International and…
In a setback for generics makers, AstraZeneca prevailed in a patent-infringement lawsuit when a federal judge validated the company’s patent for the diabetes drug Onglyza. Source: Drug Industry Daily
Aspen Pharma and Deco Pharma, the company’s distributor, face disciplinary proceedings from Spain’s antitrust authority for allegedly limiting the distribution and hiking the prices of drugs. Source: Drug Industry Daily